California to Sell Low-Cost Insulin

J. Carlisle Larsen reports California's CalRx plan to sell biosimilar glargine pens for about $45 starting January 2026.

Play episode from 02:58

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!